216 related articles for article (PubMed ID: 17420056)
1. An improved plaque reduction virus neutralization assay for human metapneumovirus.
de Graaf M; Herfst S; Schrauwen EJ; van den Hoogen BG; Osterhaus AD; Fouchier RA
J Virol Methods; 2007 Aug; 143(2):169-74. PubMed ID: 17420056
[TBL] [Abstract][Full Text] [Related]
2. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity.
Buchholz UJ; Biacchesi S; Pham QN; Tran KC; Yang L; Luongo CL; Skiadopoulos MH; Murphy BR; Collins PL
J Virol; 2005 Jun; 79(11):6588-97. PubMed ID: 15890897
[TBL] [Abstract][Full Text] [Related]
3. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.
Skiadopoulos MH; Biacchesi S; Buchholz UJ; Riggs JM; Surman SR; Amaro-Carambot E; McAuliffe JM; Elkins WR; St Claire M; Collins PL; Murphy BR
J Virol; 2004 Jul; 78(13):6927-37. PubMed ID: 15194769
[TBL] [Abstract][Full Text] [Related]
4. Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression.
Biacchesi S; Skiadopoulos MH; Yang L; Murphy BR; Collins PL; Buchholz UJ
J Virol Methods; 2005 Sep; 128(1-2):192-7. PubMed ID: 15955576
[TBL] [Abstract][Full Text] [Related]
5. Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes.
Biacchesi S; Skiadopoulos MH; Tran KC; Murphy BR; Collins PL; Buchholz UJ
Virology; 2004 Apr; 321(2):247-59. PubMed ID: 15051385
[TBL] [Abstract][Full Text] [Related]
6. Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo.
Pham QN; Biacchesi S; Skiadopoulos MH; Murphy BR; Collins PL; Buchholz UJ
J Virol; 2005 Dec; 79(24):15114-22. PubMed ID: 16306583
[TBL] [Abstract][Full Text] [Related]
7. Expeditious neutralization assay for human metapneumovirus based on a recombinant virus expressing Renilla luciferase.
Zhou M; Kitagawa Y; Yamaguchi M; Uchiyama C; Itoh M; Gotoh B
J Clin Virol; 2013 Jan; 56(1):31-6. PubMed ID: 23084005
[TBL] [Abstract][Full Text] [Related]
8. A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein.
Johnson MC; Damon IK; Karem KL
J Virol Methods; 2008 Jun; 150(1-2):14-20. PubMed ID: 18387679
[TBL] [Abstract][Full Text] [Related]
9. Immunofluorescence assay for detection of human metapneumovirus-specific antibodies by use of baculovirus-expressed fusion protein.
Ishiguro N; Ebihara T; Endo R; Ma X; Shirotsuki R; Ochiai S; Ishiko H; Kikuta H
Clin Diagn Lab Immunol; 2005 Jan; 12(1):202-5. PubMed ID: 15643008
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate.
Biacchesi S; Skiadopoulos MH; Yang L; Lamirande EW; Tran KC; Murphy BR; Collins PL; Buchholz UJ
J Virol; 2004 Dec; 78(23):12877-87. PubMed ID: 15542640
[TBL] [Abstract][Full Text] [Related]
11. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates.
Biacchesi S; Pham QN; Skiadopoulos MH; Murphy BR; Collins PL; Buchholz UJ
J Virol; 2005 Oct; 79(19):12608-13. PubMed ID: 16160190
[TBL] [Abstract][Full Text] [Related]
12. Development of a new neutralization test for measles virus.
Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
[TBL] [Abstract][Full Text] [Related]
13. Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines.
Wyde PR; Chetty SN; Jewell AM; Schoonover SL; Piedra PA
Antiviral Res; 2005 Apr; 66(1):57-66. PubMed ID: 15781133
[TBL] [Abstract][Full Text] [Related]
14. Plaque-reduction assays for human and simian immunodeficiency virus neutralization.
Nordqvist A; Fenyö EM
Methods Mol Biol; 2005; 304():273-85. PubMed ID: 16061983
[TBL] [Abstract][Full Text] [Related]
15. Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis.
Zielinska E; Liu D; Wu HY; Quiroz J; Rappaport R; Yang DP
Virol J; 2005 Nov; 2():84. PubMed ID: 16281972
[TBL] [Abstract][Full Text] [Related]
16. Detection of influenza A and B neutralizing antibodies in vaccinated ferrets and macaques using specific biotin-streptavidin conjugated antibodies.
Sirskyj D; Weltzin R; Golshani A; Anderson D; Bozic J; Diaz-Mitoma F; Azizi A
J Virol Methods; 2010 Feb; 163(2):459-64. PubMed ID: 19913054
[TBL] [Abstract][Full Text] [Related]
17. An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in vero cells and does not alter tissue tropism in hamsters.
Schickli JH; Kaur J; Ulbrandt N; Spaete RR; Tang RS
J Virol; 2005 Aug; 79(16):10678-89. PubMed ID: 16051860
[TBL] [Abstract][Full Text] [Related]
18. A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein.
Khawplod P; Inoue K; Shoji Y; Wilde H; Ubol S; Nishizono A; Kurane I; Morimoto K
J Virol Methods; 2005 Apr; 125(1):35-40. PubMed ID: 15737414
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel vaccinia-neutralization assay based on reporter-gene expression.
Manischewitz J; King LR; Bleckwenn NA; Shiloach J; Taffs R; Merchlinsky M; Eller N; Mikolajczyk MG; Clanton DJ; Monath T; Weltzin RA; Scott DE; Golding H
J Infect Dis; 2003 Aug; 188(3):440-8. PubMed ID: 12870127
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a neutralization test involving reporter gene-expressing virus-like particles of tick-borne encephalitis virus.
Yoshii K; Ikawa A; Chiba Y; Omori Y; Maeda J; Murata R; Kariwa H; Takashima I
J Virol Methods; 2009 Oct; 161(1):173-6. PubMed ID: 19481114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
